Latest

neuropharmacology

·March 14, 2026·9 min read

Most Insomnia Meds Don’t Worsen Sleep Apnea

New research identifies which insomnia medications protect the breath while promoting rest, debunking long-held fears about "sleep-inducing" drugs.

Featured Neuroscience

·March 10, 2026·13 min read

Why GLP-1 Drugs Affect Men and Women Differently

A new atlas reveals that GLP-1—the backbone of blockbuster weight-loss drugs—is mapped differently in the male and female brain.

Featured Neurology Neuroscience

·March 6, 2026·9 min read

70-Year-Old Drug Could Stop Epilepsy Seizures

Scientists discover that stabilizing a single ion transporter can flip the switch from seizure activity to healthy brain inhibition.

This shows a woman holding her head in pain.

Featured Neurology Neuroscience

·March 2, 2026·7 min read

Beyond Weight Loss: Ozempic Linked to Migraine Reduction

Unexpected relief. New research shows that patients taking GLP-1 drugs for diabetes or weight loss also experience fewer emergency room visits and need fewer medications for their chronic migraines.

Featured Neurology Neuroscience

·March 2, 2026·9 min read

Low-Dose Lithium May Shield Against Verbal Memory Loss

A new pilot study reveals that low-dose lithium may act as a neuroprotective shield, slowing verbal memory loss in patients at risk for Alzheimer’s.

This shows a brain in a wine glass with a syringe above it. Behind is a strand of DNA.

Featured Neuroscience

·February 21, 2026·7 min read

Mounjaro’s Active Ingredient Slashes Alcohol Intake

From weight loss to sobriety. New research reveals how the active ingredient in Mounjaro "mutes" the brain's reward system to slash alcohol cravings.

Featured Neurology Neuroscience

·February 17, 2026·6 min read

Brain Swelling Reveals Alzheimer’s Treatment Success

It’s the side effect every Alzheimer’s patient fears, but it might actually be a sign of success. New research shows brain swelling is tied to better plaque clearance.

This shows a brain with the nucleus accumbens highlighted, showing where the drug activates to prevent opioid relapse behaviors.

Featured Neuroscience Psychology

·February 13, 2026·7 min read

Glaucoma Drug Repurposed to Block Opioid Cravings and Relapse

An old drug for glaucoma might be the key to stopping opioid relapse. New research shows acetazolamide "resets" the brain's reward center to block cravings.

This shows a psychedelic image of a man's head lookin. His eyes are wide and he is looking at distant objects.

Featured Neuroscience Visual Neuroscience

·February 13, 2026·6 min read

Psychedelics Shift Brain Networks, Sparking Memory-Driven Perception

New neuroscience research shows psychedelics alter brain waves to suppress incoming visual input and boost memory-linked circuitry. This rewiring helps explain how vivid hallucinations arise, and highlights how these drugs might be used therapeutically.

This shows glowing neurons, as though they are the target scientists discovered.

Featured Genetics Neurology Neuroscience

·February 12, 2026·8 min read

New Drug Target Could Freeze Alzheimer’s in Its Tracks

Is the IDOL enzyme the key to stopping Alzheimer's? New research shows that blocking this single target can dissolve brain plaques and boost cognitive resilience. By lowering the brain's "strongest risk factor" protein, scientists have found a new way to keep neurons communicating even under attack.

Featured Neurology Neuroscience

·December 27, 2025·8 min read

Study Finds Way to Reverse Alzheimer’s

A new study challenges the long-held belief that Alzheimer’s disease cannot be reversed. Researchers showed that a severe drop in NAD+—a core energy molecule—drives Alzheimer’s pathology in both human brains and mouse models.

Brain Cancer Featured Neurology Neuroscience

·December 4, 2025·9 min read

Fungal Molecule Shows Promise Against Brain Cancer

For the first time, chemists have fully synthesized verticillin A, a notoriously complex fungal molecule with striking anticancer potential. The molecule’s fragile structure required a complete rethinking of its synthetic sequence, enabling researchers to not only recreate it but design more stable and potent derivatives.

1 2 3 … 80

neuropharmacology

Most Insomnia Meds Don’t Worsen Sleep Apnea

Why GLP-1 Drugs Affect Men and Women Differently

70-Year-Old Drug Could Stop Epilepsy Seizures

Beyond Weight Loss: Ozempic Linked to Migraine Reduction

Low-Dose Lithium May Shield Against Verbal Memory Loss

Mounjaro’s Active Ingredient Slashes Alcohol Intake

Brain Swelling Reveals Alzheimer’s Treatment Success

Glaucoma Drug Repurposed to Block Opioid Cravings and Relapse

Psychedelics Shift Brain Networks, Sparking Memory-Driven Perception

New Drug Target Could Freeze Alzheimer’s in Its Tracks

Study Finds Way to Reverse Alzheimer’s

Fungal Molecule Shows Promise Against Brain Cancer

Spiritual Distress Is a Clinical Reality in Brain Disease

Most Insomnia Meds Don’t Worsen Sleep Apnea

Ghost in the Machine: Brain Predicts Images Before We See Them

Dog-Inspired Robot: How Gestures Help AI Master the Art of “Fetch”

Subscribe